Frazier Life Sciences IX, L.P., 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), bought 1,702,876 shares at $16.00 ($5.0M) on 2020-10-20, disclosed to the SEC on 2020-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,390,376 | $0 | 0.0% |
| 2 | $16.00 | 312,500 | $5.0M | 100.0% |
| Total | $2.94 avg | 1,702,876 | $5.0M | 100% |